Ashland Inc.

Ashland Inc. (ASH) Stock Analysis

$74.370

+0.431 (+0.58%)At close

Loading chart…
High
75.100
Open
74.550
VWAP
74.18
Vol
469.40K
Mkt Cap
4.73B
Low
73.070
Amount
34.82M
EV/EBITDA, TTM
10.10

Ashland Inc. is a global additives and specialty ingredients company. The Company serves customers in a range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, personal care and pharmaceuticals. The Company's segments include Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Life Sciences segment consists of pharmaceuticals, nutrition, agricultural chemicals, diagnostic films and fine chemicals. The Personal Care segment includes functionals, microbial protectants (preservatives), skin care, sun care, oral care, hair care and household solutions. The Specialty Additives segment consists of rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive and various industrial markets. The Intermediates segment consists of the production of 1,4 butanediol (BDO) and related derivatives, including n-methyl pyrrolidone.

AI analysis of Ashland Inc. (ASH)

buy

Ashland Inc is a good buy right now due to its current price of $74.37, which is below several analyst price targets, including $83 from Wolfe Research and $85 from Deutsche Bank. The stock has shown a strong year-to-date change of +24.26% and a one-year change of +35.54%, indicating solid performance. However, investors should be cautious of the high debt-to-equity ratio of 73.48%, which poses a risk to financial stability.

Analyst Ratings (11)

-10.35% downside
Buy
8 Buy
3 Hold
0 Sell
Current: 74.37
Low
53.00
Average
66.67
High
73.00

Wolfe Research

2026-08-10

Price Target

$83

Outperform

Morgan Stanley

2026-08-06

Price Target

$78

Equal Weight

Deutsche Bank

2026-07-31

Price Target

$85

Buy

JPMorgan

2026-07-30

Price Target

$80

Overweight

UBS

2026-07-30

Price Target

$83

Buy

Valuation Metrics

The current forward P/E ratio for Ashland Inc. (ASH) is 16.78, compared to its 5-year average forward P/E of 16.64.

Forward P/E

Fair
5Y Average P/E
16.64
Current P/E
16.78
Overvalued
19.85
Undervalued
13.43

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
9.39
Current EV/EBITDA
10.10
Overvalued
14.93
Undervalued
3.85

Forward P/S

Fair
5Y Average P/S
1.93
Current P/S
1.75
Overvalued
2.37
Undervalued
1.50

Alphio AI Price Scenarios for ASH

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%ASH

$54.72

Scenario price

B

Base

Base · 50%ASH

$47.77

Scenario price

B

Bear

Bear · 25%ASH

$45.19

Scenario price

Whales holding ASH

D

Diamond Hill Capital Management, Inc.

+ HoldingASH

+5.48%

3M Return

S

Standard Investments LLC

+ HoldingASH

+4.61%

3M Return

H

Hantz Financial Services, Inc.

+ HoldingASH

+1.19%

3M Return

A

Ancora Advisors LLC

+ HoldingASH

-3.70%

3M Return

N

Newport Trust Company

+ HoldingASH

-5.34%

3M Return

O

Omega Advisors, Inc.

+ HoldingASH

-7.51%

3M Return

Events Timeline

2026-08-07 (ET)

16:30:00

Ashland Explores Potential Sale, Shares Up 5%

16:00:00

Ashland Shares Rise 4% to $75.69 on Takeover Interest Report

16:00:00

Ashland Exploring Sale After Takeover Interest, Bloomberg Reports

2026-07-28 (ET)

17:30:00

Ashland Reports Q3 Revenue of $497M, Beating Expectations

17:30:00

Ashland Reaffirms FY26 Adjusted EBITDA Expectation of $385M-$400M

News

ASH FAQ — answered by Alphio AI

Ashland Inc. is a global additives and specialty ingredients company. The Company serves customers in a range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, personal care and pharmaceuticals. The Company's segments include Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Life Sciences segment consists of pharmaceuticals, nutrition, agricultural chemicals, diagnostic films and fine chemicals. The Personal Care segment includes functionals, microbial protectants (preservatives), skin care, sun care, oral care, hair care and household solutions. The Specialty Additives segment consists of rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive and various industrial markets. The Intermediates segment consists of the production of 1,4 butanediol (BDO) and related derivatives, including n-methyl pyrrolidone. It operates in the Basic Materials sector (WHOLESALE-CHEMICALS & ALLIED PRODUCTS industry).

Ashland Inc is a good buy right now due to its current price of $74.37, which is below several analyst price targets, including $83 from Wolfe Research and $85 from Deutsche Bank. The stock has shown a strong year-to-date change of +24.26% and a one-year change of +35.54%, indicating solid performance. However, investors should be cautious of the high debt-to-equity ratio of 73.48%, which poses a risk to financial stability.

11 analysts cover ASH: 8 rate it Buy, 3 Hold and 0 Sell. The average price target is 66.67.

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten